Cargando…
Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report
So far, ovarian cancer has still been the most lethal gynecological malignancy. The chemotherapy and targeted medication are the mainstay for the recurrent ovarian cancer treatment. About 70% of the advanced-stage cases will relapse. Ascites-derived organoid is a pre-clinical model for the precise p...
Autores principales: | Chen, Wanyi, Fang, Po-Han, Zheng, Bin, Liang, Yue, Mao, Yiwen, Jiang, Xuefeng, Tang, Qionglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351532/ https://www.ncbi.nlm.nih.gov/pubmed/37465723 http://dx.doi.org/10.2147/IJWH.S405010 |
Ejemplares similares
-
Ascites-Derived Organoids to Depict Platinum Resistance in Gynaecological Serous Carcinomas
por: Arias-Diaz, Andrea Estrella, et al.
Publicado: (2023) -
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients
por: Choi, Wonyoung, et al.
Publicado: (2023) -
Recurrent abdominal pain and bloody ascites
por: Sung, Chih-Chien, et al.
Publicado: (2011) -
RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer
por: Wang, Yan, et al.
Publicado: (2023) -
Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
por: Psilopatis, Iason, et al.
Publicado: (2022)